Ergoteles’s Zymeworks ZYME Stock Holding History

Ergoteles’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-59,457	Closed	-$366K	–	1959
2022 Q3	$366K	Buy	+59,457	New	+$358K	0.01%	888
2022 Q2	–	Sell	-67,149	Closed	-$440K	–	2062
2022 Q1	$440K	Buy	+67,149	New	+$598K	0.02%	707

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ergoteles's ZYME Position: Q4 2022 in Review

Ergoteles sold out of Zymeworks (ZYME) in Q4 2022, closing a stake of 59,457 shares — an estimated $366K sold.

Ergoteles first reported a position in ZYME in Q1 2022 and held it in 2 quarters. The position peaked at $440K in Q1 2022. 96 funds tracked by Wall St. Rank hold ZYME as of Q4 2022.

Ergoteles reported no remaining Zymeworks position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 59,457 Zymeworks shares in Q4 2022, an estimated $366K.
Ergoteles first reported a position in Zymeworks in Q1 2022 and held it in 2 quarters.
Ergoteles's Zymeworks position peaked at $440K in Q1 2022.
96 funds tracked by Wall St. Rank held Zymeworks as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.